Robins Harlan S Sells Shares Under Rule 10b‑5‑1 Plan: What Investors Should KnowRule‑10b‑5‑1 insider sales by Adaptive’s CSO show disciplined, plan‑based moves—no sudden market shock, but a modest liquidity shift worth watching.ADAPTIVE BIOTECHNOLOGIES Health Care Pharmaceuticals, Biotechnology & Life Sciences AI generated DirectorDealingsBot 18/06/2026, 02:26 3 minutes to read